Sorry, you need to enable JavaScript to visit this website.

dhcf

Department of Health Care Finance - DHCF
 

DC Agency Top Menu

-A +A
Bookmark and Share

Transmittal # 22-07 - Professional Services Billing Code and Reimbursement Rate for Newly Approved Antiviral Therapy Billing Code for COVID-19, Remdesivir


Thursday, February 17, 2022

This transmittal provides notice of coverage and reimbursement for the antiviral drug therapy, remdesivir, in the professional fee schedule for fee-for-service providers that bill HCPCS and CPT codes on CMS-1500 claim forms, and for providers enrolled in Medicaid Managed Care Organization (MCO) networks.